This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Raptor Pharmaceutical Corp (RPTP)

NASDAQ: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Aug 2012
Sales 69.50M 16.87M 0.00 0.00
Cost of Sales 6.75M 783.00K 0.00 0.00
Gross Operating Profit 62.74M 16.09M 0.00 0.00
Selling, General, and Administrative Expenses 56.65M 37.95M 8.97M 14.72M
Research & Development 43.48M 29.18M 8.96M 21.44M
Operating Income before D & A (EBITDA) -37.39M -51.04M -17.93M -36.17M
Depreciation & Amortization 2.66M 870.00K 91.00K 211.00K
Interest Income 76.00K 188.00K 160.00K 340.00K
Other Income - Net 1.46M -10.87M -1.44M -2.81M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -38.52M -62.59M -19.30M -38.85M
Interest Expense 13.97M 6.83M 83.00K 3.00K
Pre-Tax Income -52.49M -69.42M -19.38M -38.85M
Income Taxes 54.00K 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -52.54M -69.42M -19.29M -38.64M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -52.54M -69.42M -19.29M -38.64M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -52.54M -69.42M -19.29M -38.64M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-52.54M -69.42M -19.29M -38.64M
Preferred Dividends
Net Income Available To Common -52.54M -69.42M -19.29M -38.64M
Basic EPS from Continuing Ops. -0.83 -1.20 -0.37 -0.80
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.83 -1.20 -0.37 -0.80
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.83 -1.20 -0.37 -0.80
Basic Normalized Net Income/Share -0.83 -1.20 -0.37 -0.80
EPS fr Continuing Ops. -0.83 -1.20 -0.37 -0.80
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.83 -1.20 -0.37 -0.80
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.83 -1.20 -0.37 -0.80
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.83 -1.20 -0.37 -0.80
Dividends Paid per Share 0.00 0.00 0.00 0.00
RPTP News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

RPTP Raptor Pharmaceutical Corp

Chart of RPTP

Analysts Ratings for RPTP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET RPTP ANALYST REPORT

RPTP Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs